
businessJul 3, 20267:40pending
Custom Health targets U.S. growth with connected pharmacy platform and TSX debut
About this episode
Custom Health CEO Shane Bishop joined Steve Darling from to discuss the company’s technology-enabled pharmacy platform, expansion strategy, and growth opportunities following its recent listing on the Toronto Stock Exchange under the ticker CHLT.
Bishop explained that Custom Health has evolved from addressing medication administration challenges in long-term care into a connected healthcare platform that integrates company-owned pharmacies, in-home medication dispensing devices, remote clinicians, and physicians. The platform collects patient data up to four times a day through connected medication devices and integrates the information with electronic health records to provide clinicians with real-time treatment recommendations.
One of the company’s key growth areas is pain management in the United States. Bishop said the platform provides full chain-of-custody tracking for opioid medications while collecting patient-reported pain data, allowing clinicians to identify opportunities to safely reduce opioid use. As he noted, “We’ve actually managed to lower the amount of opioids patients take by 27%.”
Bishop highlighted Custom Health’s acquisition strategy, with the company targeting pharmacies in markets where reimbursement models are already established. Bishop said owning pharmacies enables the company to deploy its technology consistently while combining acquisition-driven expansion with organic patient growth.
Looking ahead, Bishop expects the majority of future growth to come from the United States, where reimbursement structures are more favorable for the company’s connected care services, while continuing to pursue opportunities in Canada.
He added that the company’s recent TSX listing provides greater access to capital markets, supporting continued investment in technology deployment, pharmacy acquisitions, and long-term expansion of its connected healthcare platform.
#proactiveinvestors #customhealth #tsx #nhlt #pharma #DigitalHealth #ConnectedCare #HealthcareTechnology #Pharmacy #Telehealth #TSX #HealthTech #PatientCare #HealthcareInnovation
Get every episode summarized
Each time Proactive - Interviews for investors publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Proactive - Interviews for investors

Titan Minerals extends gold-silver mineralisation at Dynasty
Proactive - Interviews for investors
Sep 9, 20263:46failed

Krakatoa Resources: Zopkhito drilling extends gold-antimony potential
Proactive - Interviews for investors
Sep 9, 20264:07failed

Gaming Realms CEO: Content growth accelerating as company expands into new marke...
Proactive - Interviews for investors
Sep 9, 20262:59failed

genedrive CEO: NHS adoption and global expansion drive point-of-care testing pus...
Proactive - Interviews for investors
Sep 9, 20268:49failed